Emmes is excited to share the significant progress being made in clinical studies we undertake for clients and to give you a look inside some of our own news.
Research Shows Lithium as an Effective Treatment for Pediatric Bipolar Disorder
The Emmes Corporation today announced that three of its statisticians, Dr. Ravinder Anand, Dr. Traci Clemons and Karen Martz, co-authored a pivotal study that examined lithium as a treatment for pediatric bipolar I disorder. The study was published in the October issue of Pediatrics.
Emmes Recognized in New Research Published by the Journal of the American Medical Association
The Emmes Corporation today announced that one of its principal investigators and statisticians, Dr. Traci Clemons, co-authored a study that was just published by the Journal of the American Medical Association (JAMA).
Emmes Announces FDA Clearance of New Medical Device
The New "Mercy TAPE" Estimates Pediatric Weight with Greater Accuracy, Giving Doctors a Better Tool for Determining Prescription Dosage.
EMMES Wins IDIQ Contract
The EMMES Corporation today announced that it has been awarded an indefinite delivery, indefinite quantity (IDIQ) contract to become part of a clinical studies network established by the Biomedical Advanced Research and Development Authority (BARDA) to perform studies needed to develop medical countermeasures against agents of bioterrorism, pandemic influenza, and other public health threats.
Anne Lindblad Promoted to President/CEO of The EMMES Corporation
The EMMES Corporation today announced that Dr. Anne Lindblad, executive vice president, has been promoted to president and chief executive officer. Lindblad replaces Dr. Donald (Don) Stablein, who has been named past president.